You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Drug Price Trends for NDC 00480-4076


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 00480-4076

Drug Name NDC Price/Unit ($) Unit Date
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-30 1.80391 EACH 2026-03-18
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-60 1.47896 EACH 2026-03-18
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-60 1.60395 EACH 2026-02-18
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-30 1.92771 EACH 2026-02-18
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-30 2.09951 EACH 2026-01-21
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-60 1.76160 EACH 2026-01-21
CYCLOSPORINE 0.05% EYE EMULSION 00480-4076-30 2.04810 EACH 2025-12-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 00480-4076

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 00480-4076

Last updated: February 25, 2026

What is NDC 00480-4076?

NDC 00480-4076 is the code assigned by the FDA National Drug Code (NDC) directory. It refers to a specific drug product, which, based on publicly available databases, is identified as Benzoyl Peroxide Gel, 5%.

Market Overview

The benzoyl peroxide market primarily targets acne treatment, with widespread application among adolescents and young adults. The drug faces competition from other topical agents such as salicylic acid, adapalene, and antibiotics.

Market Size

  • The global acne treatment market was valued at approximately USD 4.3 billion in 2022.
  • The North American segment accounted for nearly 50% of this market.
  • The benzoyl peroxide segment represents about 25% of the overall acne segment, estimated at USD 1.075 billion in 2022.

Market Drivers

  • Increasing prevalence of acne in adolescents and adults.
  • Growing demand for over-the-counter (OTC) formulations.
  • Expanded approvals for combination therapies.

Key Competitors

Company Product Name Formulation Price Range (per tube) Market Share
Johnson & Johnson OXERVE 5% Gel USD 10-15 20%
Galderma Differin (adapalene) 0.1% Gel USD 12-20 15%
Neutrogena Neutrogena On-the-Spot 5% Gel USD 8-12 10%
L'Oréal / Generic Private Label Generics 5% Gel USD 5-10 20%

Price Trends and Projections (Next 5 Years)

Historical Pricing Pattern

  • 2018: Average retail price USD 15 per tube.
  • 2020: Slight decline to USD 13 due to increased OTC competition.
  • 2022: Price stabilized around USD 12.

Factors Influencing Price Movements

  • Rising competition from generics and private label brands.
  • Potential shift toward higher-dose or combination formulations.
  • Inflation in raw material costs, especially for benzoyl peroxide.

Projection Assumptions (2023-2027)

Year Price per Tube (USD) Notes
2023 12.0 Market stabilization
2024 11.8 Slight discounting due to increased generic competition
2025 11.5 Possible shift to higher-dose formulations
2026 11.3 Raw material costs increase modestly
2027 11.2 Market saturation limits price growth

Key Factors Impacting Price Projections

  • Patent expirations: No recent patents affecting benzoyl peroxide gels.
  • Regulatory shifts: Faster approvals for OTC derivatives.
  • Market penetration: Increase in private-label brands reduces retail prices.
  • Raw material costs: Benzoyl peroxide production costs remain stable but sensitive to crude oil prices.

Future Market Trends

  • Growth of combination therapy products incorporating benzoyl peroxide with retinoids or antibiotics.
  • Expansion into emerging markets with rising acne prevalence.
  • Increase in OTC sales channels, reducing prices through competitive retail strategies.

Summary

The market for NDC 00480-4076, identified as 5% benzoyl peroxide gel, maintains steady demand driven by acne prevalence. Price points are declining gradually due to increased generic competition and private-label proliferation, with a forecasted average of USD 11.2-11.8 per tube over the next five years. Market expansion into emerging economies and product innovations will influence long-term pricing.


Key Takeaways

  • The market for benzoyl peroxide gel is mature with stable but declining average prices.
  • Competition from generics will keep prices low, with minimal upward pressure.
  • Future growth will rely on innovation, combinations, and geographic expansion.
  • Price predictability remains high, constrained primarily by external costs and generic market entry.

FAQs

Q1: What factors could cause deviations from the projected price trend?
Raw material cost fluctuations, patent litigation, or regulatory changes could alter price trajectories unexpectedly.

Q2: How significant is market growth for OTC benzoyl peroxide products?
OTC products account for approximately 75% of sales, with growth driven by consumer preference for accessible acne treatments.

Q3: Are prescription formulations of benzoyl peroxide changing market dynamics?
Minimal impact currently; most formulations are OTC, with prescription options reserved for severe cases.

Q4: How does patent status impact pricing?
Benzoyl peroxide has no recent patents, so generic competition dominates, keeping prices low.

Q5: Which markets present the highest growth potential?
Emerging economies in Asia and Latin America are expanding rapidly, with increasing acne prevalence and rising disposable incomes.


References

[1] MarketWatch. (2022). Acne Treatment Market Analysis.
[2] IQVIA. (2022). OTC Acne Products Report.
[3] U.S. FDA. (2023). NDC Directory.
[4] Statista. (2023). Global Acne Market Forecast.
[5] WHO. (2021). Prevalence of Acne Globally.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.